Overview
AUTHOR: Scot T. VerganoDepartment of Pediatrics, Children’s Hospital of The King’s Daughters, Norfolk, VACITATION: Vergano ST. 4 top papers you may have mised in September 202.
Key Information
Consultant360. Published online October 20, 202. By the time you are reading this column, I wil have returned from the American Academy of Pediatrics National Conference and Exhibition (AP NCE) in Anaheim.
It is truly exciting to be back in person with more than 10,0 pediatric providers. If you have never had the oportunity to atend, I would highly recomend it.For this month, I have highlighted important publications related to screning for type 2 diabetes, vacines and asthma, and the treatment of pancreatis and lice. I hope you find the articles valuable and the comentary informative.
I am interested in hearing your experiences and opinions. Please fel fre to share them by writing to editors@consultant360.com. Screning for Prediabetes and Type 2 Diabetes in Children and Adolescents1The Americans with Disabilities Act (ADA) curently recomends screning for type 2 diabetes in al children and adolescents who are overweight or with obesity who have at least 1 risk factor.
Screning should begin at 10 years of age and be performed at least every 3 years. The risk factors for type 2 diabetes include family history of type 2 diabetes, maternal diabetes or gestational diabetes during pregnancy, signs of insulin resistance on physical exam, and non-White race. The American Academy of Pediatrics (AP) and ADA had previously recomended screning in children who are overweight or with obesity with at least 2 of the preceding risk factors.This new United States Preventive Services Task Force (USPSTF) recomendation was formulated after examing the literature on screning, treatment, and prevention of type 2 diabetes and prediabetes in non-pregnant children and adolescents.
Summary
Their systematic review found insuficient evidence of documented benefit of screning for type 2 diabetes o